95
Views
0
CrossRef citations to date
0
Altmetric
Articles

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications: a single center experience

ORCID Icon, , , , , & show all
Pages 301-307 | Received 29 Mar 2021, Accepted 14 Jun 2022, Published online: 23 Jun 2022

References

  • Available from: https://statistik.incanet.se/urinblasecancer/
  • Rouprêt M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62–79.
  • Kriegmair MC, Younsi N, Hiller K, et al. Single- vs multiple-layer wound closure for flank incisions: results of a prospective, randomised, double-blinded multicentre study. BJU Int. 2021;127(1):64–70.
  • Rassweiler JJ, Schulze M, Marrero R, et al. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol. 2004;46(6):690–697.
  • Ilic D, Evans S, Allan C, et al. Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a cochrane systematic review. BJU Int. 2018;121(6):845–853.
  • Novara G, La Falce S, Kungulli A, et al. Robot-assisted partial nephrectomy. Int J Surg. 2016;36(Pt C):554–559.
  • Zeuschner P, Vollmer SG, Linxweiler J, et al. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a retrospective cohort study across ten years. Surg Oncol. 2021;38:101607.
  • Lee H, Kim HJ, Lee SE, et al. Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma. PLOS One. 2019;14(1):e0210401.
  • Campi R, Cotte J, Sessa F, et al. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience. World J Urol. 2019;37(11):2303–2311.
  • De Groote R, Decaestecker K, Larcher A, et al. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions. J Robot Surg. 2020;14(1):211–219.
  • Veccia A, Antonelli A, Francavilla S, et al. Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases. World J Urol. 2020;38(4):845–852.
  • Liedberg F, Sörenby A. Re: improving management of upper tract urothelial carcinoma. Eur Urol. 2020;78(4):631.
  • Voskuilen CS, Schweitzer D, Jensen JB, et al. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma. Eur Urol Oncol. 2020;3(1):73–79.
  • Liedberg F. Evaluation of lymph node surgery in patients with upper urinary tract carcinoma. ISRCTN registry. 2015.
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.
  • Jancke G, Aljabery F, Gudjonsson S, et al. Port-site metastases after robot-assisted radical cystectomy: is there a publication bias? Eur Urol. 2018;73(4):641–642.
  • Kang Q, Yu Y, Yang B. Incidence of port site metastasis in laparoscopic radical nephroureterectomy: single-institution experience. Urology. 2019;131:130–135.
  • Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56(3):520–526.
  • Sui W, Wallis CJD, Luckenbaugh AN, et al. The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urology. 2021;147:135–142.
  • Tay LJ, Chatterton K, Colemeadow J, et al. Improving management of upper tract urothelial carcinoma. BJU Int. 2020;126(1):5–6.
  • Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395(10232):1268–1277.
  • McIntire PJ, Snow JT, Robinson BD, et al. Improved correlation of urinary cytology specimens using the Paris system in biopsy-proven upper tract urothelial carcinomas. Cancer Cytopathol. 2018;126(7):498–504.
  • Almås B, Øverby S, Halvorsen OJ, et al. Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma. Scand J Urol. 2021;55(2):100–107.
  • Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcome of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol. 2016;70(6):1052–1068.
  • Baboudjian M, Al Balushi K, Michel F, et al. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage. World J Urol. 2020;38(1):159–165.
  • Afferi L, Abufaraj M, Soria F, et al. A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. Minerva Urol Nefrol. 2021;74(1):49–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.